The triple-negative breast cancer (TNBC) subtype expresses none of the three receptors (ER and PgR absent, and HER2 negative, respectively) and is generally more aggressive and with a poorer prognosis than the other subtypes [9,10]. This evidence concerns the gene ESR1 and triple-negative breast carcinoma.